Tobias Thaler is a notable inventor based in Köln, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and methods. With a total of seven patents to his name, Thaler's work has had a considerable impact on drug formulation and synthesis.

Latest Patents

Among his latest patents is the invention titled "Polymorphic form of N-{6-(hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide." This invention relates to crystalline forms of the compound, processes for their preparation, pharmaceutical compositions comprising them, and their use in controlling various disorders. Another significant patent is for the "Synthesis of indazoles," which describes a novel method for preparing a 2-substituted indazole and the use of intermediate compounds in this synthesis.

Career Highlights

Tobias Thaler is currently employed at Bayer Pharma Aktiengesellschaft, where he continues to innovate and develop new pharmaceutical solutions. His work at Bayer has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Thaler has worked alongside notable colleagues such as Johannes Platzek and Nicolas Guimond. Their collaborative efforts have further advanced the research and development of new pharmaceutical compounds.

Conclusion

Tobias Thaler's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and synthesis.

This text is generated by artificial intelligence and may not be accurate.